Shire Laboratories, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shire Laboratories, Inc..The latest application filed is for "sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms".

Company Profile

0.25.6

Shire Laboratories, Inc. - Rockville MD
Shire Laboratories, Inc. -
Shire Laboratories, Inc. - Gaithersbury MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Oral pulsed dose drug delivery system Grant RE41,148 - Burnside , et al. February 23, 2	2010-02-23
Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms App 20060210625 - Kidane; Argaw	2006-09-21
Self-emulsifying formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability and/or reduced food effect Grant 7,022,337 - Liang , et al. April 4, 2	2006-04-04
Oral capsule formulation with increased physical stability Grant 7,011,846 - Shojaei , et al. March 14, 2	2006-03-14
Once daily dosage forms of trospium App 20050191351 - Kidane, Argaw ; et al.	2005-09-01
Micellar systems useful for delivery of lipophilic or hydrophobic compounds App 20050191343 - Liang, Likan	2005-09-01
Sustained release delivery of amphetamine salts Grant 6,913,768 - Couch , et al. July 5, 2	2005-07-05
Compositions of quaternary ammonium compounds containing bioavailability enhancers App 20050123606 - Kidane, Argaw	2005-06-09
Pharmaceutical compositions including ACE/NEP inhibitors and bioavailability enhancers Grant 6,890,918 - Burnside , et al. May 10, 2	2005-05-10
System for osmotic delivery of pharmaceutically active agents Grant 6,838,093 - Flanner , et al. January 4, 2	2005-01-04
Osmotic drug delivery system Grant 6,814,979 - Rudnic , et al. November 9, 2	2004-11-09
Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles Grant 6,811,794 - Burnside , et al. November 2, 2	2004-11-02
Solid oral dosage form Grant 6,793,934 - Burnside , et al. September 21, 2	2004-09-21
Fluidization of particles for encapsulation in oral dosage pharmaceutical products Grant 6,772,801 - Shojaei , et al. August 10, 2	2004-08-10
Sustained release delivery of amphetamine salts App 20040059002 - Couch, Richard A. ; et al.	2004-03-25
Solid solution beadlet Grant 6,692,767 - Burnside , et al. February 17, 2	2004-02-17
Oral pulsed dose drug delivery system Grant 6,605,300 - Burnside , et al. August 12, 2	2003-08-12
Soluble form osmotic dose delivery system Grant 6,514,532 - Rudnic , et al. February 4, 2	2003-02-04
Soluble form osmotic dose delivery system App 20020102306 - Rudnic, Edward M. ; et al.	2002-08-01
Rapid immediate release oral dosage form Grant 6,384,020 - Flanner , et al. May 7, 2	2002-05-07
Soluble form osmotic dose delivery system Grant 6,361,796 - Rudnic , et al. March 26, 2	2002-03-26
Oral pulsed dose drug delivery system Grant 6,322,819 - Burnside , et al. November 27, 2	2001-11-27
Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles Grant 6,287,599 - Burnside , et al. September 11, 2	2001-09-11
Soluble form osmotic dose delivery system Grant 6,284,276 - Rudnic , et al. September 4, 2	2001-09-04
Osmotic drug delivery system Grant 6,110,498 - Rudnic , et al. August 29, 2	2000-08-29
Emulsified drug delivery systems Grant 5,952,004 - Rudnic , et al. September 14, 1	1999-09-14
Oral induction of tolerance to parenterally administered non-autologous polypeptides Grant 5,948,407 - McGuinness , et al. September 7, 1	1999-09-07
Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine Grant 5,912,013 - Rudnic , et al. June 15, 1	1999-06-15
Emulsified drug delivery system Grant 5,897,876 - Rudnic , et al. April 27, 1	1999-04-27
Oral acyclovir delivery Grant 5,883,103 - Burnside , et al. March 16, 1	1999-03-16
Oral insulin delivery Grant 5,824,638 - Burnside , et al. October 20, 1	1998-10-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.